株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

創傷治療用バイオロジクスの世界市場:産業分析、地域別の見通し、応用可能性、競合市場シェア、予測

Wound Care Biologics Market Size By Product, By Wound Type, By End-Use Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2019 - 2025

発行 Global Market Insights Inc. 商品コード 786055
出版日 ページ情報 英文 120 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.62円で換算しております。
Back to Top
創傷治療用バイオロジクスの世界市場:産業分析、地域別の見通し、応用可能性、競合市場シェア、予測 Wound Care Biologics Market Size By Product, By Wound Type, By End-Use Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2019 - 2025
出版日: 2019年01月22日 ページ情報: 英文 120 Pages
概要

当レポートでは、世界の創傷治療用バイオロジクス市場について調査分析し、産業の考察、セグメント別の市場分析、地域別の分析、主要企業などについて、体系的な情報を提供しています。

第1章 調査手法

第2章 エグゼクティブサマリー

第3章 創傷治療用バイオロジクス産業の考察

  • 産業区分
  • 産業情勢
  • 産業影響力
  • 規制情勢
  • 成長可能性分析
  • 競合情勢
  • ファイブフォース分析
  • PESTEL分析

第4章 創傷治療用バイオロジクス市場:製品別

  • 主要セグメント動向
  • 代用皮膚
  • 局所薬

第5章 創傷治療用バイオロジクス市場:創傷の種類別

  • 主要セグメント動向
  • 糖尿病性足潰瘍
  • 静脈性下腿潰瘍
  • 褥瘡
  • 手術創傷
  • やけど
  • その他

第6章 創傷治療用バイオロジクス市場:最終用途別

  • 主要セグメント動向
  • 病院
  • ASC
  • その他

第7章 創傷治療用バイオロジクス市場:地域別

  • 主要地域動向
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第8章 企業プロファイル

  • Amnio Technology
  • Derma Sciences
  • Integra Life Sciences
  • Kerecis
  • Mimedx Group
  • Molnlycke Health Care AB
  • Osiris Therapeutics
  • Smith & Nephew
  • Solsys Medica
  • Skye Biologics
  • Wright Medical
図表

Data Tables

  • TABLE 1. Wound care biologics industry 360 degree synopsis, 2014 - 2025
  • TABLE 2. Wound care biologics market, 2014-2025 (USD Mn)
  • TABLE 3. Wound care biologics market, by product, 2014-2025 (USD Mn)
  • TABLE 4. Wound care biologics market, by wound type, 2014-2025 (USD Mn)
  • TABLE 5. Wound care biologics market, by end-use, 2014-2025 (USD Mn)
  • TABLE 6. Wound care biologics market, by region, 2014-2025 (USD Mn)
  • TABLE 7. Industry impact forces
  • TABLE 8. Skin substitutes market size, by region, 2014-2025 (USD Mn)
  • TABLE 9. Topical Agents market size, by region, 2014-2025 (USD Mn)
  • TABLE 10. Biological market size, by region, 2014-2025 (USD Mn)
  • TABLE 11. Synthetic market size, by region, 2014-2025 (USD Mn)
  • TABLE 12. Allograft market size, by region, 2014-2025 (USD Mn)
  • TABLE 13. Xenograft market size, by region, 2014-2025 (USD Mn)
  • TABLE 14. Others market size, by region, 2014-2025 (USD Mn)
  • TABLE 15. Diabetic Foot Ulcers market size, by region, 2014-2025 (USD Mn)
  • TABLE 16. Venous Leg Ulcers market size, by region, 2014-2025 (USD Mn)
  • TABLE 17. Pressure Ulcers market size, by region, 2014-2025 (USD Mn)
  • TABLE 18. Surgical Wounds market size, by region, 2014-2025 (USD Mn)
  • TABLE 19. Burns market size, by region, 2014-2025 (USD Mn)
  • TABLE 20. Others market size, by region, 2014-2025 (USD Mn)
  • TABLE 21. Hospitals market size, by region, 2014-2025 (USD Mn)
  • TABLE 22. Ambulatory surgical centers market size, by region, 2014-2025 (USD Mn)
  • TABLE 23. Others market size, by region, 2014-2025 (USD Mn)
  • TABLE 24. North America wound care biologics market size, by country, 2014-2025 (USD Mn)
  • TABLE 25. North America wound care biologics market size, by product, 2014-2025 (USD Mn)
  • TABLE 26. North America wound care biologics market size, by wound type, 2014-2025 (USD Mn)
  • TABLE 27. North America wound care biologics market size, by end-use, 2014-2025 (USD Mn)
  • TABLE 28. U.S. wound care biologics market size, by product, 2014-2025 (USD Mn)
  • TABLE 29. U.S. wound care biologics market, by wound type, 2014-2025 (USD Mn)
  • TABLE 30. U.S. wound care biologics market size, by end-use, 2014-2025 (USD Mn)
  • TABLE 31. Canada wound care biologics market size, by product, 2014-2025 (USD Mn)
  • TABLE 32. Canada wound care biologics market size, by wound type, 2014-2025 (USD Mn)
  • TABLE 33. Canada wound care biologics market size, by end-use, 2014-2025 (USD Mn)
  • TABLE 34. Europe wound care biologics market size, by country, 2014-2025 (USD Mn)
  • TABLE 35. Europe wound care biologics market size, by product, 2014-2025 (USD Mn)
  • TABLE 36. Europe wound care biologics market size, by wound type, 2014-2025 (USD Mn)
  • TABLE 37. Europe wound care biologics market size, by end-use, 2014-2025 (USD Mn)
  • TABLE 38. Germany wound care biologics market size, by product, 2014-2025 (USD Mn)
  • TABLE 39. Germany wound care biologics market size, by wound type, 2014-2025 (USD Mn)
  • TABLE 40. Germany wound care biologics market size, by end-use, 2014-2025 (USD Mn)
  • TABLE 41. UK wound care biologics market size, by product, 2014-2025 (USD Mn)
  • TABLE 42. UK wound care biologics market size, by wound type, 2014-2025 (USD Mn)
  • TABLE 43. UK wound care biologics market size, by end-use, 2014-2025 (USD Mn)
  • TABLE 44. France wound care biologics market size, by product, 2014-2025 (USD Mn)
  • TABLE 45. France wound care biologics market size, by wound type, 2014-2025 (USD Mn)
  • TABLE 46. France wound care biologics market size, by end-use, 2014-2025 (USD Mn)
  • TABLE 47. Spain wound care biologics market size, by product, 2014-2025 (USD Mn)
  • TABLE 48. Spain wound care biologics market, by wound type, 2014-2025 (USD Mn)
  • TABLE 49. Spain wound care biologics market size, by end-use, 2014-2025 (USD Mn)
  • TABLE 50. Italy wound care biologics market size, by product, 2014-2025 (USD Mn)
  • TABLE 51. Italy wound care biologics market size, by wound type, 2014-2025 (USD Mn)
  • TABLE 52. Italy wound care biologics market size, by end-use, 2014-2025 (USD Mn)
  • TABLE 53. Asia Pacific wound care biologics market size, by country, 2014-2025 (USD Mn)
  • TABLE 54. Asia Pacific wound care biologics market size, by product, 2014-2025 (USD Mn)
  • TABLE 55. Asia Pacific wound care biologics market size, by wound type, 2014-2025 (USD Mn)
  • TABLE 56. Asia Pacific wound care biologics market size, by end-use, 2014-2025 (USD Mn)
  • TABLE 57. Japan wound care biologics market size, by product, 2014-2025 (USD Mn)
  • TABLE 58. Japan wound care biologics market size, by wound type, 2014-2025 (USD Mn)
  • TABLE 59. Japan wound care biologics market size, by end-use, 2014-2025 (USD Mn)
  • TABLE 60. China wound care biologics market size, by product, 2014-2025 (USD Mn)
  • TABLE 61. China wound care biologics market size, by wound type, 2014-2025 (USD Mn)
  • TABLE 62. China wound care biologics market size, by end-use, 2014-2025 (USD Mn)
  • TABLE 63. India wound care biologics market size, by product, 2014-2025 (USD Mn)
  • TABLE 64. India wound care biologics market size, by wound type, 2014-2025 (USD Mn)
  • TABLE 65. India wound care biologics market size, by end-use, 2014-2025 (USD Mn)
  • TABLE 66. Australia wound care biologics market size, by product, 2014-2025 (USD Mn)
  • TABLE 67. Australia wound care biologics market size, by wound type, 2014-2025 (USD Mn)
  • TABLE 68. Australia wound care biologics market size, by end-use, 2014-2025 (USD Mn)
  • TABLE 69. South Korea wound care biologics market size, by product, 2014-2025 (USD Mn)
  • TABLE 70. South Korea wound care biologics market size, by wound type, 2014-2025 (USD Mn)
  • TABLE 71. South Korea wound care biologics market size, by end-use, 2014-2025 (USD Mn)
  • TABLE 72. Latin America wound care biologics market size, by country, 2014-2025 (USD Mn)
  • TABLE 73. Latin America wound care biologics market size, by product, 2014-2025 (USD Mn)
  • TABLE 74. Latin America wound care biologics market size, by wound type, 2014-2025 (USD Mn)
  • TABLE 75. Latin America wound care biologics market size, by end-use, 2014-2025 (USD Mn)
  • TABLE 76. Brazil wound care biologics market size, by product, 2014-2025 (USD Mn)
  • TABLE 77. Brazil wound care biologics market size, by wound type, 2014-2025 (USD Mn)
  • TABLE 78. Brazil wound care biologics market size, by end-use, 2014-2025 (USD Mn)
  • TABLE 79. Mexico wound care biologics market size, by product, 2014-2025 (USD Mn)
  • TABLE 80. Mexico wound care biologics market size, by wound type, 2014-2025 (USD Mn)
  • TABLE 81. Mexico wound care biologics market size, by end-use, 2014-2025 (USD Mn)
  • TABLE 82. Argentina wound care biologics market size, by product, 2014-2025 (USD Mn)
  • TABLE 83. Argentina wound care biologics market size, by wound type, 2014-2025 (USD Mn)
  • TABLE 84. Argentina wound care biologics market size, by end-use, 2014-2025 (USD Mn)
  • TABLE 85. MEA wound care biologics market size, by country, 2014-2025 (USD Mn)
  • TABLE 86. MEA wound care biologics market size, by product, 2014-2025 (USD Mn)
  • TABLE 87. MEA wound care biologics market size, by wound type, 2014-2025 (USD Mn)
  • TABLE 88. MEA wound care biologics market size, by end-use, 2014-2025 (USD Mn)
  • TABLE 89. South Africa wound care biologics market size, by product, 2014-2025 (USD Mn)
  • TABLE 90. South Africa wound care biologics market size, by wound type, 2014-2025 (USD Mn)
  • TABLE 91. South Africa wound care biologics market size, by end-use, 2014-2025 (USD Mn)
  • TABLE 92. Saudi Arabia wound care biologics market size, by product, 2014-2025 (USD Mn)
  • TABLE 93. Saudi Arabia wound care biologics market size, by wound type, 2014-2025 (USD Mn)
  • TABLE 94. Saudi Arabia wound care biologics market size, by end-use, 2014-2025 (USD Mn)
  • TABLE 95. UAE wound care biologics market size, by product, 2014-2025 (USD Mn)
  • TABLE 96. UAE wound care biologics market size, by wound type, 2014-2025 (USD Mn)
  • TABLE 97. UAE wound care biologics market size, by end-use, 2014-2025 (USD Mn)

Charts & Figures

  • FIG 1. Industry segmentation
  • FIG 2. Global wound care biologics market, 2014 - 2025 (USD Mn)
  • FIG 3. Growth potential analysis, by product
  • FIG 4. Growth potential analysis, by wound type
  • FIG 5. Growth potential analysis, by end-use
  • FIG 6. Porter's analysis
  • FIG 7. Strategy dashboard
  • FIG 8. PESTEL analysis
目次
Product Code: 2925

Title:
Wound Care Biologics Market Size By Product (Skin Substitutes {Biological [Allograft, Xenograft], Synthetic}, Topical Agents), By Wound Type (Diabetic Foot Ulcers, Venous Leg Ulcers, Pressure Ulcers, Surgical Wounds, Burns), By End-Use (Hospitals, Ambulatory Surgical Centers) Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, Brazil, Mexico, Argentina, South Africa, UAE, Saudi Arabia), Application Potential, Competitive Market Share & Forecast, 2019 - 2025.

Wound Care Biologics Market will exceed USD 2.5 billion by 2025; as per a new research report.

Rising government initiatives that helps in lowering the cost of wound care biologics will prove beneficial for industry growth. Recently developed wound care biologic products are relatively expensive and thus, would create affordability issues. Therefore, government in developing countries implements certain initiatives that will resolve the affordability issues and will subsequently increase their demand over the forthcoming years. Moreover, the government in developed countries is engaged in lowering the prices of wound healing products being utilized by ambulatory surgical centers and public hospitals that further stimulates the wound care biologics market growth.

Rising geriatric population will also impact the wound care biologics market positively. Geriatric population is susceptible to chronic diseases that raises the demand for surgical procedures. Extensive usage of wound healing products in surgical and post-surgical procedures will substantially enhance wound care biologics market growth. However, lack of trained physicians in underdeveloped countries for carrying out the tissue engineering and other wound care treatment may affect the wound care biologic industry growth during the forecast period.

Topical agent segment will witness 8.9% CAGR during the analysis period. Topical agents include ointments, creams, lotions. Recently developed topical agents are also known to stimulate the process of wound healing. Doctors and physicians have high preference for using topical agents as they possess similar level of efficacy as that of the oral formulations. Also, topical agents have fewer side effects that will increase its demand over other wound healing products accelerating the segmental growth.

Venous leg ulcers segment was valued USD 195.0 million in 2018 and is expected to have enormous growth throughout the analysis period. Venous leg ulcers are often caused due to obstruction in the functioning of blood supply from legs to heart for purification. The veins in the leg can disrupt and stop blood supply causing weakening of skin due to increased pressure on the limbs. This reduces the rate of wound healing and makes a person more susceptible to leg ulcers on occurrence of any sort of minor injury. Skin substitutes are preferred in the treatment of venous leg ulcers that should propel segmental growth.

Hospitals segment will grow at 8.8% till 2025 as a result of growing utilization of wound healing products such as topical agents and skin substitutes in hospitals. Growing cases of diabetic foot ulcers, venous leg ulcers, surgical wounds and burns will increase the demand for wound care biologic products utilized in healing the post-surgical wounds thus, positively influencing the segmental growth.

India wound care biologics market accounted for 19.5% revenue share of the Asia Pacific wound care biologics market in 2018 and is anticipated to witness exponential growth during forecast timeframe. Also, there are improvements in the Indian public healthcare system that ensures availability of superior quality wound healing products. Moreover, prevalence of chronic diseases such as diabetes and STDs such as AIDS is high amongst the Indian population that increases the demand for surgical procedures proving beneficial for industry growth. Additionally, public organizations take initiatives to ensure optimal availability of medical resources that includes variety of wound dressings augmenting the industry growth in foreseeable future.

Key industry players operational in wound care biologics market includes Smith & Nephew, Integra Life Sciences, Molnlycke Health Care AB, Mimedx Group, Wright Medical, Osiris Therapeutics, Kerecis, Amnio Technology, Derma Sciences, Solsys Medica and Skye Biologics. Prominent industry players implement several organic as well as inorganic growth strategies for maintaining their market share. For instance, in January 2017, Integra Life Sciences acquired Derma Sciences. This acquisition will enable Integra Life Sciences to expand its product portfolio that will also help in increasing company's revenue.

Table of Contents

Chapter 1. Methodology

  • 1.1. Methodology
  • 1.2. Market definitions
  • 1.3. Forecast parameters
  • 1.4. Data sources
    • 1.4.1. Secondary
      • 1.4.1.1. Paid sources
      • 1.4.1.2. Unpaid sources
    • 1.4.2. Primary

Chapter 2. Executive Summary

  • 2.1. Wound care biologics industry 360 degree synopsis, 2014 - 2025
    • 2.1.1. Business trends
    • 2.1.2. Product trends
    • 2.1.3. Wound type trends
    • 2.1.4. End-use trends
    • 2.1.5. Regional trends

Chapter 3. Wound Care Biologics Industry Insights

  • 3.1. Industry segmentation
  • 3.2. Industry landscape, 2014 - 2025
  • 3.3. Industry impact forces
    • 3.3.1. Growth drivers
      • 3.3.1.1. Rising incidences of burn injuries in developing and underdeveloped regions
      • 3.3.1.2. Increasing geriatric population globally
      • 3.3.1.3. Innovations in wound care biologics in North America
      • 3.3.1.4. Government initiatives regarding wound care treatment in Europe and North America
    • 3.3.2. Industry pitfalls and challenges
      • 3.3.2.1. High cost of wound treatment
      • 3.3.2.2. Lack of trained physicians in underdeveloped economies
  • 3.4. Regulatory landscape
  • 3.5. Growth potential analysis
    • 3.5.1. By product
    • 3.5.2. By wound type
    • 3.5.3. By end-use
  • 3.6. Competitive landscape, 2018
    • 3.6.1. Strategy dashboard
  • 3.7. Porter's analysis
  • 3.8. PESTEL analysis

Chapter 4. Wound Care Biologics Market, By Product

  • 4.1. Key segment trends
  • 4.2. Skin substitutes
    • 4.2.1. Market size, by region, 2014-2025 (USD Million)
    • 4.2.2. Biological
      • 4.2.2.1. Market size, by region, 2014-2025 (USD Million)
      • 4.2.2.2. Allograft
        • 4.2.2.2.1. Market size, by region, 2014-2025 (USD Million)
      • 4.2.2.3. Xenograft
        • 4.2.2.3.1. Market size, by region, 2014-2025 (USD Million)
      • 4.2.2.4. Others
        • 4.2.2.4.1. Market size, by region, 2014-2025 (USD Million)
    • 4.2.3. Synthetic
      • 4.2.3.1. Market size, by region, 2014-2025 (USD Million)
  • 4.3. Topical agents
    • 4.3.1. Market size, by region, 2014-2025 (USD Million)

Chapter 5. Wound Care Biologics Market, By Wound Type

  • 5.1. Key segment trends
  • 5.2. Diabetic foot ulcers
    • 5.2.1. Market size, by region, 2014-2025 (USD Million)
  • 5.3. Venous leg ulcers
    • 5.3.1. Market size, by region, 2014-2025 (USD Million)
  • 5.4. Pressure ulcers
    • 5.4.1. Market size, by region, 2014-2025 (USD Million)
  • 5.5. Surgical wounds
    • 5.5.1. Market size, by region, 2014-2025 (USD Million)
  • 5.6. Burns
    • 5.6.1. Market size, by region, 2014-2025 (USD Million)
  • 5.7. Others
    • 5.7.1. Market size, by region, 2014-2025 (USD Million)

Chapter 6. Wound Care Biologics Market, By End-use

  • 6.1. Key segment trends
  • 6.2. Hospitals
    • 6.2.1. Market size, by region, 2014-2025 (USD Million)
  • 6.3. Ambulatory surgical centers
    • 6.3.1. Market size, by region, 2014-2025 (USD Million)
  • 6.4. Others
    • 6.4.1. Market size, by region, 2014-2025 (USD Million)

Chapter 7. Wound Care Biologics Market, By Region

  • 7.1. Key regional trends
  • 7.2. North America
    • 7.2.1. Market size, by country, 2014 - 2025 (USD Million)
    • 7.2.2. Market size, by product, 2014 - 2025 (USD Million)
    • 7.2.3. Market size, by wound type, 2014 - 2025 (USD Million)
    • 7.2.4. Market size, by end-use, 2014 - 2025 (USD Million)
    • 7.2.5. U.S.
      • 7.2.5.1. Market size, by product, 2014 - 2025 (USD Million)
      • 7.2.5.2. Market size, by wound type, 2014 - 2025 (USD Million)
      • 7.2.5.3. Market size, by end-use, 2014 - 2025 (USD Million)
    • 7.2.6. Canada
      • 7.2.6.1. Market size, by product, 2014 - 2025 (USD Million)
      • 7.2.6.2. Market size, by wound type, 2014 - 2025 (USD Million)
      • 7.2.6.3. Market size, by end-use, 2014 - 2025 (USD Million)
  • 7.3. Europe
    • 7.3.1. Market size, by country, 2014 - 2025 (USD Million)
    • 7.3.2. Market size, by product, 2014 - 2025 (USD Million)
    • 7.3.3. Market size, by wound type, 2014 - 2025 (USD Million)
    • 7.3.4. Market size, by end-use, 2014 - 2025 (USD Million)
    • 7.3.5. Germany
      • 7.3.5.1. Market size, by product, 2014 - 2025 (USD Million)
      • 7.3.5.2. Market size, by wound type, 2014 - 2025 (USD Million)
      • 7.3.5.3. Market size, by end-use, 2014 - 2025 (USD Million)
    • 7.3.6. France
      • 7.3.6.1. Market size, by product, 2014 - 2025 (USD Million)
      • 7.3.6.2. Market size, by wound type, 2014 - 2025 (USD Million)
      • 7.3.6.3. Market size, by end-use, 2014 - 2025 (USD Million)
    • 7.3.7. UK
      • 7.3.7.1. Market size, by product, 2014 - 2025 (USD Million)
      • 7.3.7.2. Market size, by wound type, 2014 - 2025 (USD Million)
      • 7.3.7.3. Market size, by end-use, 2014 - 2025 (USD Million)
    • 7.3.8. Italy
      • 7.3.8.1. Market size, by product, 2014 - 2025 (USD Million)
      • 7.3.8.2. Market size, by wound type, 2014 - 2025 (USD Million)
      • 7.3.8.3. Market size, by end-use, 2014 - 2025 (USD Million)
    • 7.3.9. Spain
      • 7.3.9.1. Market size, by product, 2014 - 2025 (USD Million)
      • 7.3.9.2. Market size, by wound type, 2014 - 2025 (USD Million)
      • 7.3.9.3. Market size, by end-use, 2014 - 2025 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Market size, by country, 2014 - 2025 (USD Million)
    • 7.4.2. Market size, by product, 2014 - 2025 (USD Million)
    • 7.4.3. Market size, by wound type, 2014 - 2025 (USD Million)
    • 7.4.4. Market size, by end-use, 2014 - 2025 (USD Million)
    • 7.4.5. China
      • 7.4.5.1. Market size, by product, 2014 - 2025 (USD Million)
      • 7.4.5.2. Market size, by wound type, 2014 - 2025 (USD Million)
      • 7.4.5.3. Market size, by end-use, 2014 - 2025 (USD Million)
    • 7.4.6. Japan
      • 7.4.6.1. Market size, by product, 2014 - 2025 (USD Million)
      • 7.4.6.2. Market size, by wound type, 2014 - 2025 (USD Million)
      • 7.4.6.3. Market size, by end-use, 2014 - 2025 (USD Million)
    • 7.4.7. India
      • 7.4.7.1. Market size, by product, 2014 - 2025 (USD Million)
      • 7.4.7.2. Market size, by wound type, 2014 - 2025 (USD Million)
      • 7.4.7.3. Market size, by end-use, 2014 - 2025 (USD Million)
    • 7.4.8. Australia
      • 7.4.8.1. Market size, by product, 2014 - 2025 (USD Million)
      • 7.4.8.2. Market size, by wound type, 2014 - 2025 (USD Million)
      • 7.4.8.3. Market size, by end-use, 2014 - 2025 (USD Million)
    • 7.4.9. South Korea
      • 7.4.9.1. Market size, by product, 2014 - 2025 (USD Million)
      • 7.4.9.2. Market size, by wound type, 2014 - 2025 (USD Million)
      • 7.4.9.3. Market size, by end-use, 2014 - 2025 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Market size, by country, 2014 - 2025 (USD Million)
    • 7.5.2. Market size, by product, 2014 - 2025 (USD Million)
    • 7.5.3. Market size, by wound type, 2014 - 2025 (USD Million)
    • 7.5.4. Market size, by end-use, 2014 - 2025 (USD Million)
    • 7.5.5. Brazil
      • 7.5.5.1. Market size, by product, 2014 - 2025 (USD Million)
      • 7.5.5.2. Market size, by wound type, 2014 - 2025 (USD Million)
      • 7.5.5.3. Market size, by end-use, 2014 - 2025 (USD Million)
    • 7.5.6. Mexico
      • 7.5.6.1. Market size, by product, 2014 - 2025 (USD Million)
      • 7.5.6.2. Market size, by wound type, 2014 - 2025 (USD Million)
      • 7.5.6.3. Market size, by end-use, 2014 - 2025 (USD Million)
    • 7.5.7. Argentina
      • 7.5.7.1. Market size, by product, 2014 - 2025 (USD Million)
      • 7.5.7.2. Market size, by wound type, 2014 - 2025 (USD Million)
      • 7.5.7.3. Market size, by end-use, 2014 - 2025 (USD Million)
  • 7.6. MEA
    • 7.6.1. Market size, by country, 2014 - 2025 (USD Million)
    • 7.6.2. Market size, by product, 2014 - 2025 (USD Million)
    • 7.6.3. Market size, by wound type, 2014 - 2025 (USD Million)
    • 7.6.4. Market size, by end-use, 2014 - 2025 (USD Million)
    • 7.6.5. South Africa
      • 7.6.5.1. Market size, by product, 2014 - 2025 (USD Million)
      • 7.6.5.2. Market size, by wound type, 2014 - 2025 (USD Million)
      • 7.6.5.3. Market size, by end-use, 2014 - 2025 (USD Million)
    • 7.6.6. Saudi Arabia
      • 7.6.6.1. Market size, by product, 2014 - 2025 (USD Million)
      • 7.6.6.2. Market size, by wound type, 2014 - 2025 (USD Million)
      • 7.6.6.3. Market size, by end-use, 2014 - 2025 (USD Million)
    • 7.6.7. UAE
      • 7.6.7.1. Market size, by product, 2014 - 2025 (USD Million)
      • 7.6.7.2. Market size, by wound type, 2014 - 2025 (USD Million)
      • 7.6.7.3. Market size, by end-use, 2014 - 2025 (USD Million)

Chapter 8. Company Profiles

  • 8.1. Amnio Technology
    • 8.1.1. Business overview
    • 8.1.2. Financial data
    • 8.1.3. Product landscape
    • 8.1.4. Strategic outlook
    • 8.1.5. SWOT analysis
  • 8.2. Derma Sciences
    • 8.2.1. Business overview
    • 8.2.2. Financial data
    • 8.2.3. Product landscape
    • 8.2.4. Strategic outlook
    • 8.2.5. SWOT analysis
  • 8.3. Integra Life Sciences
    • 8.3.1. Business overview
    • 8.3.2. Financial data
    • 8.3.3. Product landscape
    • 8.3.4. Strategic outlook
    • 8.3.5. SWOT analysis
  • 8.4. Kerecis
    • 8.4.1. Business overview
    • 8.4.2. Financial data
    • 8.4.3. Product landscape
    • 8.4.4. Strategic outlook
    • 8.4.5. SWOT analysis
  • 8.5. Mimedx Group
    • 8.5.1. Business overview
    • 8.5.2. Financial data
    • 8.5.3. Product landscape
    • 8.5.4. Strategic outlook
    • 8.5.5. SWOT analysis
  • 8.6. Mölnlycke Health Care AB
    • 8.6.1. Business overview
    • 8.6.2. Financial data
    • 8.6.3. Product landscape
    • 8.6.4. Strategic outlook
    • 8.6.5. SWOT analysis
  • 8.7. Osiris Therapeutics
    • 8.7.1. Business overview
    • 8.7.2. Financial data
    • 8.7.3. Product landscape
    • 8.7.4. Strategic outlook
    • 8.7.5. SWOT analysis
  • 8.8. Smith & Nephew
    • 8.8.1. Business overview
    • 8.8.2. Financial data
    • 8.8.3. Product landscape
    • 8.8.4. Strategic outlook
    • 8.8.5. SWOT analysis
  • 8.9. Solsys Medica
    • 8.9.1. Business overview
    • 8.9.2. Financial data
    • 8.9.3. Product landscape
    • 8.9.4. Strategic outlook
    • 8.9.5. SWOT analysis
  • 8.10. Skye Biologics
    • 8.10.1. Business overview
    • 8.10.2. Financial data
    • 8.10.3. Product landscape
    • 8.10.4. Strategic outlook
    • 8.10.5. SWOT analysis
  • 8.11. Wright Medical
    • 8.11.1. Business overview
    • 8.11.2. Financial data
    • 8.11.3. Product landscape
    • 8.11.4. Strategic outlook
    • 8.11.5. SWOT analysis
Back to Top